05/14/2026
A new Pediatrics study finds that maternal RSV vaccination and infant immunization are safe and result in high levels of neutralizing antibodies whether they are given alone or in combination.
Both the infant immunization and maternal vaccination were thoroughly tested in separate clinical trials, and most infants only need one for protection. However, both are called for in certain high-risk situations as well as when the vaccination status of the pregnant parent is unknown or when the infant is born less than 14 days after their pregnant parent was vaccinated.
Researchers studied 181 mother-infant pairs to compare RSV protection combinations. No serious vaccine-related side effects were reported in mothers or babies.
“RSV remains a primary cause of hospitalizations and early infection may lead to a lifetime of increased morbidity from a respiratory disease,” authors of the commentary wrote. “These products represent tremendous advances in our ability to protect the most vulnerable infants.”
Read about the clinical trial in AAP News: https://bit.ly/42kqPof